Core Publications

2025

Voos KM, et al. (2025) Ankyrin-B modulates mitochondrial fission in skeletal muscle and is required for optimal endurance exercise capacity. Nature communications , 16 (1) , 7671. (PMID:40854882)
Langer HT, et al. (2025) Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans. medRxiv : the preprint server for health sciences. (PMID:40766140)
Hu MY, et al. (2025) Human-length Telomeres Limit Regeneration of Liver Epithelial Cells in Mice. Cellular and molecular gastroenterology and hepatology, 101655. (PMID:41038571)
Geisler CE, et al. (2025) Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis. Science translational medicine, 17 (808), eadu6764. (PMID:40700519)

Nunn E, et al. (2024) Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Molecular metabolism, 80, 101880. (PMID:38218536)
Song F, et al. (2024) Wnt7b overexpression in osteoblasts stimulates bone formation and reduces obesity in mice on a high-fat diet. JBMR plus, 8 (11), ziae122. (PMID:39434845)
Doan KV, et al. (2024) Cardiac NAD+ depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics. Nature cardiovascular research, 3 (10), 1236. (PMID:39294272)

If you want to schedule an experiment, please reach out to our Technical Director, Corey Holman at holmanc@pennmedicine.upenn.edu.

The Rodent Metabolic Phenotyping Core is part of The Institute for Diabetes, Obesity, & Metabolism in the Smilow Center for Translational Research.